Weekly profile.ABRAXIS BIOSCIENCE INC. (ABBI Advanced Breast Biopsy Instrument (ABBI) Uses a rotating circular knife and thin heated electrical wire to remove a large cylinder of abnormal breast tissue. Mentioned in: Fibrocystic Condition of the Breast ) Business Overview Abraxis BioScience, Inc., formerly American Pharmaceutical Partners, Inc., incorporated in 2001, is a pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products. It manufactures products in each of the three basic forms, in which injectable products are sold: liquid, powder and lyophilized ly·oph·i·lize tr.v. ly·oph·i·lized, ly·oph·i·liz·ing, ly·oph·i·liz·es To freeze-dry (blood plasma or other biological substances). [lyophil(ic) + -ize. , or freeze-dried. The company has the right to sell Abraxane, a nanoparticle injectable oncology product, in North America. In January 2005, American BioScience (ABI Abi (ā`bī) [short for Abijah], in the Bible, King Hezekiah's mother. (Application Binary Interface) A specification for a specific hardware platform combined with the operating system. )'s new drug application (NDA (Non Disclosure Agreement) An agreement signed between two parties that have to disclose confidential information to each other in order to do business. In general, the NDA states why the information is being divulged and stipulates that it cannot be used for any ) for Abraxane was approved by United States Food and Drug Administration United States Food and Drug Administration (FDA), n.pr a unit of the Public Health Service created to protect the health of the nation against impure and unsafe foods, drugs, and cosmetics. (FDA) and the company launched the product on February 7, 2005. On November 27, 2005, the company entered into a merger agreement with ABI. During the year ended December 31, 2005, the company has 23 abbreviated new drug applications pending and over 70 product candidates under development across oncology, anti-infective and critical care product categories. The company's wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. , Pharmaceutical Partners of Canada, Inc., markets injectable pharmaceutical products in Canada. Income Statement LTM * 2005 ** Revenue (millions) $514.9 $518.8 Operating Inc. ome (millions) 132.9 130.3 Net Inc. ome (millions) 89.7 86.4 EPS $1.22 $1.17 Summary Headquarters: Los Angeles Market Cap: $3.8 billion Dividend Yield: N/A P/E Ratio: 16.82 * Latest Twelve Months Ending 1212005 ** Fiscal Year Ending 12/2005 [GRAPHIC OMITTED] |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion